Nifuta is nifedipine extended-release tablets, Xuanning is levamlodipine maleate, the active ingredients of the two are different, it can not be said which drug has a better effect on lowering blood pressure, it is recommended to follow the doctor’s advice to choose the appropriate drug treatment. Nifedipine extended-release tablets, the main ingredient of which is nifedipine, can be used to treat angina pectoris, hypertension and other diseases. After using the drug, adverse reactions such as dizziness and edema may occur. It is not suitable for patients with cardiogenic shock and myocardial infarction. Levamlodipine maleate, the main component of which is amlodipine, can be used to treat chronic stable angina pectoris, essential hypertension and other diseases. Adverse reactions such as flushing and fatigue may occur after use of the drug. Patients with severe hypotension should not use this drug. The above drugs have different ingredients and it is impossible to generalize which drug is more effective. Patients should use the drug under the supervision of a doctor.